Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 190

1.

Association between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination Setting.

Peto TJ, Tripura R, Lee SJ, Althaus T, Dunachie S, Nguon C, Dhorda M, Promnarate C, Chalk J, Imwong M, von Seidlein L, Day NP, Dondorp AM, White NJ, Lubell Y.

PLoS One. 2016 Jul 7;11(7):e0158656. doi: 10.1371/journal.pone.0158656. eCollection 2016.

2.

Artemisinin-Resistant Plasmodium falciparum Malaria.

Fairhurst RM, Dondorp AM.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0013-2016.

PMID:
27337450
3.

Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings.

Thwaites CL, Lundeg G, Dondorp AM; sepsis in resource-limited settings–expert consensus recommendations group of the European Society of Intensive Care Medicine (ESICM) and the Mahidol-Oxford Research Unit (MORU) in Bangkok, Thailand.

Intensive Care Med. 2016 Jun 21. [Epub ahead of print] No abstract available.

PMID:
27324344
4.

Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria.

Wattanakul T, Teerapong P, Plewes K, Newton PN, Chierakul W, Silamut K, Chotivanich K, Ruengweerayut R, White NJ, Dondorp AM, Tarning J.

Malar J. 2016 Apr 27;15(1):244. doi: 10.1186/s12936-016-1283-9.

5.

The Relationship between Poverty and Healthcare Seeking among Patients Hospitalized with Acute Febrile Illnesses in Chittagong, Bangladesh.

Herdman MT, Maude RJ, Chowdhury MS, Kingston HW, Jeeyapant A, Samad R, Karim R, Dondorp AM, Hossain MA.

PLoS One. 2016 Apr 7;11(4):e0152965. doi: 10.1371/journal.pone.0152965. eCollection 2016.

6.

Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.

Tun KM, Jeeyapant A, Imwong M, Thein M, Aung SS, Hlaing TM, Yuentrakul P, Promnarate C, Dhorda M, Woodrow CJ, Dondorp AM, Ashley EA, Smithuis FM, White NJ, Day NP.

Malar J. 2016 Mar 31;15:185. doi: 10.1186/s12936-016-1240-7.

7.

Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies.

Tripura R, Peto TJ, Chalk J, Lee SJ, Sirithiranont P, Nguon C, Dhorda M, von Seidlein L, Maude RJ, Day NP, Imwong M, White NJ, Dondorp AM.

Malar J. 2016 Mar 24;15:181. doi: 10.1186/s12936-016-1224-7.

8.

Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.

Leang R, Canavati SE, Khim N, Vestergaard LS, Borghini Fuhrer I, Kim S, Denis MB, Heng P, Tol B, Huy R, Duparc S, Dondorp AM, Menard D, Ringwald P.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):3884-90. doi: 10.1128/AAC.00039-16. Print 2016 Jul.

PMID:
26926629
9.

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.

Awab GR, Imwong M, Pukrittayakamee S, Alim F, Hanpithakpong W, Tarning J, Dondorp AM, Day NP, White NJ, Woodrow CJ.

Malar J. 2016 Feb 25;15:121. doi: 10.1186/s12936-016-1167-z.

10.

Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach.

Canavati SE, Lawford HL, Fatunmbi BS, Lek D, Top-Samphor N, Leang R, Dondorp AM, Huy R, Kazadi WM.

Malar J. 2016 Feb 25;15:120. doi: 10.1186/s12936-016-1117-9.

11.

Critical Care in Resource-Restricted Settings.

Dondorp AM, Iyer SS, Schultz MJ.

JAMA. 2016 Feb 23;315(8):753-4. doi: 10.1001/jama.2016.0976. No abstract available.

PMID:
26903331
12.

The Cambodia Research Consortium: expediting research for malaria elimination with the emergency response to artemisinin resistance framework.

Canavati SE, Lawford HL, Fatunmbi BS, Lek D, Leang R, Top Samphor N, Dondorp AM, Huy R, Kazadi WM.

Malar J. 2016 Jan 4;15:5. doi: 10.1186/s12936-015-1062-z.

13.

Use of Blood Smears and Dried Blood Spots for Polymerase Chain Reaction-Based Detection and Quantification of Bacterial Infection and Plasmodium falciparum in Severely Ill Febrile African Children.

Wihokhoen B, Dondorp AM, Turner P, Woodrow CJ, Imwong M.

Am J Trop Med Hyg. 2016 Feb;94(2):322-6. doi: 10.4269/ajtmh.15-0532. Epub 2015 Dec 28.

14.

Retinal Changes in Uncomplicated and Severe Plasmodium knowlesi Malaria.

Govindasamy G, Barber BE, Ghani SA, William T, Grigg MJ, Borooah S, Dhillon B, Dondorp AM, Yeo TW, Anstey NM, Maude RJ.

J Infect Dis. 2016 May 1;213(9):1476-82. doi: 10.1093/infdis/jiv746. Epub 2015 Dec 15.

PMID:
26671886
15.

Exploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo.

de Haan F, Onyamboko MA, Fanello CI, Woodrow CJ, Lubell Y, Boon WP, Dondorp AM.

Malar J. 2015 Dec 15;14:503. doi: 10.1186/s12936-015-0963-1.

16.

Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report.

Plewes K, Maude RJ, Ghose A, Dondorp AM.

BMC Infect Dis. 2015 Dec 3;15:555. doi: 10.1186/s12879-015-1285-1.

17.

Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies.

Slater HC, Ross A, Ouédraogo AL, White LJ, Nguon C, Walker PG, Ngor P, Aguas R, Silal SP, Dondorp AM, La Barre P, Burton R, Sauerwein RW, Drakeley C, Smith TA, Bousema T, Ghani AC.

Nature. 2015 Dec 3;528(7580):S94-101. doi: 10.1038/nature16040.

PMID:
26633771
18.

An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand.

Imwong M, Jindakhad T, Kunasol C, Sutawong K, Vejakama P, Dondorp AM.

Sci Rep. 2015 Nov 30;5:17412. doi: 10.1038/srep17412.

19.

Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia.

Lubell Y, Blacksell SD, Dunachie S, Tanganuchitcharnchai A, Althaus T, Watthanaworawit W, Paris DH, Mayxay M, Peto TJ, Dondorp AM, White NJ, Day NP, Nosten F, Newton PN, Turner P.

BMC Infect Dis. 2015 Nov 11;15:511. doi: 10.1186/s12879-015-1272-6.

20.

Optimum population-level use of artemisinin combination therapies: a modelling study.

Nguyen TD, Olliaro P, Dondorp AM, Baird JK, Lam HM, Farrar J, Thwaites GE, White NJ, Boni MF.

Lancet Glob Health. 2015 Dec;3(12):e758-66. doi: 10.1016/S2214-109X(15)00162-X. Epub 2015 Nov 4.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk